These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 17635863)
1. Noncapsulated toxinogenic Bacillus anthracis presents a specific growth and dissemination pattern in naive and protective antigen-immune mice. Glomski IJ; Corre JP; Mock M; Goossens PL Infect Immun; 2007 Oct; 75(10):4754-61. PubMed ID: 17635863 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody against the poly-gamma-D-glutamic acid capsule of Bacillus anthracis protects mice from enhanced lethal toxin activity due to capsule and anthrax spore challenge. Jang J; Cho M; Lee HR; Cha K; Chun JH; Hong KJ; Park J; Rhie GE Biochim Biophys Acta; 2013 Mar; 1830(3):2804-12. PubMed ID: 23201204 [TBL] [Abstract][Full Text] [Related]
3. Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax. Glomski IJ; Piris-Gimenez A; Huerre M; Mock M; Goossens PL PLoS Pathog; 2007 Jun; 3(6):e76. PubMed ID: 17542645 [TBL] [Abstract][Full Text] [Related]
4. Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax. Lovchik JA; Drysdale M; Koehler TM; Hutt JA; Lyons CR Infect Immun; 2012 Jul; 80(7):2414-25. PubMed ID: 22526673 [TBL] [Abstract][Full Text] [Related]
5. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits. Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302 [TBL] [Abstract][Full Text] [Related]
6. Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax. Heninger S; Drysdale M; Lovchik J; Hutt J; Lipscomb MF; Koehler TM; Lyons CR Infect Immun; 2006 Nov; 74(11):6067-74. PubMed ID: 16923785 [TBL] [Abstract][Full Text] [Related]
7. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model. Peterson JW; Comer JE; Baze WB; Noffsinger DM; Wenglikowski A; Walberg KG; Hardcastle J; Pawlik J; Bush K; Taormina J; Moen S; Thomas J; Chatuev BM; Sower L; Chopra AK; Stanberry LR; Sawada R; Scholz WW; Sircar J Infect Immun; 2007 Jul; 75(7):3414-24. PubMed ID: 17452469 [TBL] [Abstract][Full Text] [Related]
8. Bacillus cereus G9241 makes anthrax toxin and capsule like highly virulent B. anthracis Ames but behaves like attenuated toxigenic nonencapsulated B. anthracis Sterne in rabbits and mice. Wilson MK; Vergis JM; Alem F; Palmer JR; Keane-Myers AM; Brahmbhatt TN; Ventura CL; O'Brien AD Infect Immun; 2011 Aug; 79(8):3012-9. PubMed ID: 21576337 [TBL] [Abstract][Full Text] [Related]
9. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits. Lee DY; Chun JH; Ha HJ; Park J; Kim BS; Oh HB; Rhie GE FEMS Immunol Med Microbiol; 2009 Nov; 57(2):165-72. PubMed ID: 19732139 [TBL] [Abstract][Full Text] [Related]
10. A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis. Majumder S; Das S; Somani V; Makam SS; Joseph KJ; Bhatnagar R Sci Rep; 2018 May; 8(1):7242. PubMed ID: 29740033 [TBL] [Abstract][Full Text] [Related]
11. Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model. Loving CL; Khurana T; Osorio M; Lee GM; Kelly VK; Stibitz S; Merkel TJ Infect Immun; 2009 Jan; 77(1):255-65. PubMed ID: 18955474 [TBL] [Abstract][Full Text] [Related]
12. Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax. Drysdale M; Heninger S; Hutt J; Chen Y; Lyons CR; Koehler TM EMBO J; 2005 Jan; 24(1):221-7. PubMed ID: 15616593 [TBL] [Abstract][Full Text] [Related]
17. In vivo dynamics of active edema and lethal factors during anthrax. Rougeaux C; Becher F; Ezan E; Tournier JN; Goossens PL Sci Rep; 2016 Mar; 6():23346. PubMed ID: 26996161 [TBL] [Abstract][Full Text] [Related]
18. Molecular pathogenesis of Bacillus anthracis infection. Little SF; Ivins BE Microbes Infect; 1999 Feb; 1(2):131-9. PubMed ID: 10594977 [TBL] [Abstract][Full Text] [Related]
19. New aspects of the infection mechanisms of Bacillus anthracis. Zakowska D; Bartoszcze M; Niemcewicz M; Bielawska-Drózd A; Kocik J Ann Agric Environ Med; 2012; 19(4):613-8. PubMed ID: 23311776 [TBL] [Abstract][Full Text] [Related]
20. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax. Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]